TCTR20240617001
Not Yet Recruiting
Phase 1
Effectiveness of botulinum toxin injection into masseter muscle to lower face appearance and masticatory function
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mahidol university
- Enrollment
- 15
- Status
- Not Yet Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Healthy volunteer
- •2\. Any sexual, age more than 20 years old
- •3\. Able to read, write and understand Thai language
- •4\. No history of administering botulinum toxin type A into masseter
- •muscle within the last 1 year
Exclusion Criteria
- •1\. History of botulinum toxin allergy
- •2\. Infection at the injected area
- •3\. Patients with neuromuscular disorders (e.g., Myasthenia gravis)
- •4\. Pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
Botox injection in 1st toe to treat spasticityThe application of Botox is described in the technical sheet for spasticity and has already been applied to the foot. This is how we speak of a phase IV clinical trial, with a low level of intervention.Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2020-005653-24-ESClínica Integral del pie-Ana Sans120
Completed
Phase 2
Evaluation of the effect of botulinum toxin and Profhilo hyaluronic acid injection in rejuvenation of the neck.Horizontal neck lines.IRCT20201204049589N1Tehran University of Medical Sciences20
Active, Not Recruiting
N/A
The effect of Botulinum toxin A injections for overactive bladder on detrusor contractility - Botulinum toxin A and detrusor contractilityEUCTR2007-004650-93-NLniversity Medical Center Groningen
Not Yet Recruiting
Phase 4
The effect of Botulinum toxin A injections for overactive bladder on detrusor contractilityoveractive bladderurine incontinence10046590NL-OMON31265niversitair Medisch Centrum Groningen10
Active, Not Recruiting
Phase 1
Evaluation of botulinum toxin injection efficacy in the treatment of head essential tremorTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2015-000162-59-FRCHU Clermont-Ferrand120